Julie McGregor, MD
Assistant Professor of Medicine

Email: julie_mcgregor@med.unc.edu
Phone: (919) 445-2672
Fax: (919) 966-4251
Office Location: 7030 Burnett-Womack

Specialty Areas: Glomerulonephritis, Vasculitis, Interventional Nephrology

Chronology: BS: Virginia Tech, 1999; MD: Wake Forest School of Medicine, 2004; Internship 2005/Residency 2007: University of North Carolina; Nephrology Fellow: University of North Carolina, 2006-2009; Research Fellow, 2010: University of North Carolina; Assistant Professor of Medicine: University of North Carolina, 2011-present.

Dr. McGregor conducts clinical and translational research in vasculitis, specifically ANCA disease and glomerulonephritis. Dr. McGregor is ASDIN certified in interventional nephrology: balloon assisted maturation of fistulas, fistulograms, angioplasty, stent placement, central stenosis intervention and thrombectomy.

Recent Publications:

McGregor JG, Negrete-Lopez R, Poulton CJ, Kidd JM, Katsanos SL, Goetz L, Hu Y, Nachman PH, Falk RJ, Hogan SL: Adverse events and infectious burden, microbes and temporal outline from immunosuppressive therapy in antineutrophil cytoplasmic antibody-associated vasculitis with native renal function. NDT, 2015 Apr; 30 Suppl 1:i171-81.

McGregor JG, Hogan SL, Kotzen ES, Poulton CJ, Hu Y, Negrete-Lopez R, Kidd JM, Katsanos SL, Bunch DO, Nachman PH, Falk RJ:  Rituximab as an immunosuppressant in antineutrophil cytoplasmic antibody-associated vasculitis.  NDT, 2015 Apr; 30 Suppl 1:i123-31.

Bunch DO, Mendoza CE, Aybar LT, Kotzen ES, Colby KR, Hu Y, Hogan SL, Poulton CJ, Schmitz JL, Falk RJ, Nachman PH, Pendergraft WF, McGregor JG:  Gleaning relapse risk from B Cell phenothyp: decreased CD5+B cells portend a shorter time to relapse after B cell depletion in patients with ANCA-associated vasculitis.  Ann Rheum Dis.  2015 Sep;74(9):1784-6.

Berg EA, McGregor JG, Burkart ME, Poulton CJ, Hu Y, Falk RJ, Hogan SL:  J Autoimmune Dis Rheumatol. 2014 Nov 1; 2(3): 74-91.

McGregor JG, Hogan SL, Hu Y, Jennette CE, Falk RJ, Nachman PH:  Glucocorticoids and Relapse and Infection Rates in Anti-Neutrophil Cytoplasmic Antibody Disease.  CJASN, 2012 Feb; 7(2):240-7.

Poster Presentations:

American Society of Nephrology Renal Week Conference 2010:  Corticosteroid Therapy Beyond 6 Months Does Not Decrease Relapses In ANCA Disease. Authors - JulieAnne G. McGregor, MD, Susan L. Hogan, PhD, Yichun Hu, Caroline E. Jennette, Ronald J. Falk, MD, FASN , Patrick H. Nachman, MD, FASN.  Session Title: CKD, AKI, DM Clinical: Diabetes and Vasculitides, Poster Board #: SA-PO2254.

American Society of Nephrology Renal Week Conference 2010:  Microparticle Tissue Factor Activity is Increased in PR3-ANCA Vasculitis Patients with Active Disease,  Authors: Madelyn Burkart, Sam Glover, Julie McGregor, Elisabeth Berg, Yichun Hu, Susan Hogan, Ronald Falk, Raj Kasthuri, Donna Bunch.  Session Title: CKD, AKI, DM Clinical: Diabetes and Vasculitides, Poster Board #: SA-PO2255.

15th International Vasculitis & ANCA Workshop Oral Presentation Wednesday, May 18th, 2011. Glucocorticoid Use Beyond 6 Months Does Not Prevent Relapses But Increases Risk of Infection. Authors: JulieAnne G. McGregor, MD, Susan L. Hogan, MPH, PhD, Yichun Hu, MS, Caroline E. Jennette, MSW, Ronald J. Falk, MD, FASN, Patrick H. Nachman, MD, FASN.


Back to Faculty & Staff Profiles Page